Why shouldn't we use warfarin alone to treat acute venous thrombosis?

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.

Toni Choueiri, MD
Division of Medicine, The Cleveland Clinic

Steven R. Deitcher, MD
Director, Clinical Thrombosis and Vascular Research, Section of Vascular Medicine, Department of Cardiovascular Medicine, The Cleveland Clinic

Address: Steven R. Deitcher, MD, Section of Vascular Medicine, Department of Cardiovascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland,OH 44195; e-mail [email protected]

Dr. Deitcher has received grant or research support from Aventis, Pharmacia, and Bristol-Myers Squibb Pharma and is a consultant for and on the speakers’ bureau of Aventis.